Apotex Inc

Apotex Inc., founded in 1974 by Dr. Barry Sherman, is the largest Canadian-owned pharmaceutical company.  From its two-employee, 5,000 square-feet beginning in Toronto, the company has grown to employ over 10,000 people in research, development, manufacturing, and distribution facilities worldwide.  The Canadian operations of the Apotex Group of Companies have over 5,500 employees.  Extensive investments in Canadian facilities include over 3 million square feet in manufacturing and R&D facilities in Richmond Hill, Toronto, Etobicoke, Brantford, Windsor, and Winnipeg.  Key distribution centers are located in Calgary and Toronto.   Apotex’s Quality Vision “Commitment to Excellence” is supported by a sustainable compliance culture and core values of Pride, Accountability, Integrity, and Diligence for all employees.  This Vision and these Values are the strategic and tactical drivers of our operational, regulatory, and overall business success.   Out of the total employee base, there are close to 2,000 scientific staff including 110 PhDs.  Apotex produces more than 300 generic medicines in over 4,000 dosages and formats which, in Canada, are used to fill over 89 million prescriptions a year – the largest amount of any pharmaceutical company in this country. Manufacturing capabilities have risen steadily to close to 30 billion dosages per annum. Furthermore, its operational efficiency and utilization rates are the best in the industry and rival the consumer products industry.  Its Research and Development expenditures represent 16.4% (2012),thereby placing Apotex in the top 13 R&D companies in Canada and first within the Pharmaceutical industry.  Plans are to have expenditures of more than $2.1 billion on R&D over the next 10 years.   Apotex also owns and has investments in separate companies including Apotex Pharmachem Inc., located in Brantford Ontario, which is the largest pharmaceutical fine chemicals R&D and manufacturing facility in Canada, with additional sites in Winnipeg, Mexico, China, and India.  The production and R&D sites in India are located in Bangalore and play an essential and strategic role to the facilities in Canada.   Today, Apotex is a necessary and trusted member of Canada’s healthcare community.  The company’s pharmaceuticals can be found in virtually every pharmacy and healthcare facility in Canada and are exported to over 115 countries around the globe.  Apotex has established a presence through subsidiaries, joint ventures, or licensing agreements in several countries including the USA, Netherlands, Belgium, Spain, Czech Republic, Mexico, Australia, New Zealand, Poland, Saudi Arabia and others.  Healthcare professionals around the world rely on Apotex for quality affordable medications.   For additional information please go to www.apotex.com

pharmaceuticals, generic drugs, clinical trials